5 Biotech ETFs
The biotech industry is of interest to many ETF investors, yet it has been relatively flat in returns for the last 10 years and has underperformed when compared to other US equities. There are 5 plays in the ETF Biotech space: iShares Nasdaq Biotech ETF (IBB) is the biggest ETF in the market in terms [...]
Health Care ETFs Ride Legislation Wave
After a special Sunday vote on health care reform in the House, health care ETFs look strong, posting early gains ahead of a bill that will add 30 million customers to their client list. Although health care has been stagnating through 2010, new legislation could improve profits at the nation’s largest health care providers. Year-to-date, [...]
ProShares Files for Five Leveraged Inverse ETFs
ProShares has filed with the SEC to create five new leveraged or inverse funds, expanding the already largest lineup of leveraged products by any one issuer. The new funds tackle popular sectors such as China, bio-tech, basic materials and real estate. The five new funds are: 1. Short FTSE/Xinhua China (YXI) 2. Ultra Nasdaq Biotechnology [...]
Health Care ETFs Experience Calm before the Storm
Since health care became a pinnacle talking point in Washington, health care ETFs have been relatively flat. Investors have exhibited indecision regarding which companies may make a good investment should Congress pass its $1 trillion health care insurance reform bill. The new bill could bring as many as 43 million more Americans to hospital waiting [...]
Overturned Ban “Stemulates” Bio-Tech ETFs
President Obama removed the ban on federally funded stem cell research this week, and investors rejoiced by multiplying investments in the bio-tech industry. The industry hopes that further federal funding at the academic level, as well as increased awareness of stem cell research, will help open up a field that stagnated for eight years under [...]
Healthy Outlook for Biotechnology ETF in 2009
After significantly outperforming the broad market in 2008, biotechnology is under the microscope of many analysts to project which direction the industry will go in 2009. In just the first week of the year, biotech stocks are already showing signs of optimism. A biotechnology ETF that captures the industry’s recent strength is iShares Nasdaq Biotechnology [...]
First Trust’s Transfer of ETFs to NYSE Arca Accomplished
As part of the NYSE Arca’s acquisition of the American Stock Exchange (AMEX), First Trust has successfully relocated 29 of its ETFs from the AMEX to the NYSE Arca. According to a Business Wire press release, the ETFs are affiliated with various indexes and have begun trading on the new exchange today, November 6, 2008. [...]
Non-Financial PowerShares ETF Undergoes Name Change
An Invesco PowerShares ETF, closely associated with the popular technology-tracking Qs ETF, has just been renamed. The Market Wire press release reports that the original ETF, known as PowerShares NextQ Portfolio (PNXQ: Quote, Profile, Advanced Chart, News) will now be identified as PowerShares NQX Portfolio. Though the ETF has been renamed, all other aspects of [...]
Two Barclays ETFs Complete Move to New Exchanges
After first announcing an exchange transfer of two iShares ETFs on September 2, 2008, Barclays Global Investors (BGI) has completed the transition of two ETFs to new exchanges. The two ETFs involved in the move are iShares Nasdaq Biotechnology Index Fund ETF (IBB: Quote, Profile, Advanced Chart, News) and iShares S&P 100 Index Fund ETF [...]
Two More Invesco ETFs Begin Trading on NASDAQ
After nearly a month since the announcement of two new Invesco PowerShares ETFs, the environment-friendly transportation ETF and biotechnology ETF will now begin trading on the NASDAQ Stock Market. The GlobeNewswire press release informs that PowerShares Global Progressive Transportation Portfolio ETF (PTRP) and PowerShares Global Biotech Portfolio ETF (PBTQ) will each follow their respective index [...]
